https://www.thebodypro.com/tag/news

News

The Latest

Promo Image

This Week in HIV Research: How Low (an Atripla Dose) Can You Go?

Atripla may be just as effective when taken every other day; poor antiretroviral prescription fill rates after hospitalization; U.S. progress against UNAIDS targets; hepatitis C transmission clustering in France.

UK Patient Likely to Be the Second Person Cured of HIV: Two Further Cases at CROI 2019 of HIV Remission After Allogenic Stem Cell Transplants Img

UK Patient Likely to Be the Second Person Cured of HIV: Two Further Cases at CROI 2019 of HIV Remission After Allogenic Stem Cell Transplants

The procedure used in this case was similar to that used in the only previously confirmed HIV cure case, "Berlin patient" Timothy Ray Brown, albeit with a somewhat less aggressive approach.

New Study Triggers Concerns Over Use of Molecular HIV Surveillance Img

New Study Triggers Concerns Over Use of Molecular HIV Surveillance

This study identified some information about transgender women's sexual networks in Los Angeles. But activists worry about privacy and the potential that the surveillance method will be used in HIV criminalization cases.

Hepatitis C Treatment Slashes Risk of Cancer and Improves Life Expectancy, Study Finds Img

Hepatitis C Treatment Slashes Risk of Cancer and Improves Life Expectancy, Study Finds

Prior studies have indicated that hepatitis C direct-acting antivirals reduce the risk of hepatocellular carcinoma, but this is the first large prospective study to compare outcomes among treated and untreated patients.

Promo Image

This Week in HIV Research: The Clinical Impacts of HIV Stigma

Internalized HIV stigma, depression, and adherence in women; what “internalized HIV stigma” actually means; tenofovir-containing gel and genital herpes prevention; the neurocognitive effects of cerebrospinal HIV escape.

Promo Image

This Week in HIV Research: The Science of Risk

Traditional factors vs. HIV-specific factors in non-communicable complications; frailty and fracture risk among women; lipid measurements and coronary risks; new data on efavirenz and birth defects.

PrEP Use Doesn't Increase STIs Among Black MSM, New Study Shows Img

PrEP Use Doesn't Increase STIs Among Black MSM, New Study Shows

Some have expressed concern that, as PrEP use increases in the U.S., so will the transmission of other STIs. A new study pushes back against that worry.

Promo Image

This Week in HIV Research: Rethinking PrEP Guidelines

Alternate PrEP guideline recommendations; partner notification and onward HIV transmission; shifting causes of death among HIV/HCV-coinfected people; correlates of lower adherence among people on methadone maintenance.

Promo Image

This Week in HIV Research: Don't Assume PrEP Use Increases STI Rates

New for the week ending March 15: Study of young black MSM finds no link between PrEP uptake and STI incidence; HIV risk scores and PrEP usage; impact of youth-tailored HIV services; long-acting antiretroviral interest among younger people with HIV.

Neisseria gonorrhoeae bacterium

Chlamydia and Gonorrhea Responsible for 10% of New HIV Infections Among MSM, According to New Study

Sexually transmitted infections are on the rise in the U.S. A recent study explored whether chlamydia and gonorrhea infections have a direct relationship to HIV rates and, if so, how large the impact is.